Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Improving clinical care of patients in Nipah outbreaks: moving beyond 'compassionate use'.

Journal article

Hassan MZ. et al, (2025), The Lancet regional health. Southeast Asia, 33

Clinical characterisation and outcomes of human clade IIb mpox virus disease - a European multicentre observational cohort study (MOSAIC).

Journal article

Pesonel E. et al, (2025), Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Embedding treatment in stronger care systems

Journal article

Rojek A. et al, (2024), The Lancet Infectious Diseases

Presentation and Outcomes of Lassa Fever in Children in Nigeria: A Prospective Cohort Study (LASCOPE)

Journal article

Duvignaud A. et al, (2024), Journal of the Pediatric Infectious Diseases Society, 13, 513 - 522

Group sequential designs for clinical trials when the maximum sample size is uncertain

Journal article

Yarahmadi A. et al, (2024), Statistics in Medicine, 43, 4667 - 4683

Community Involvement in an Outbreak-One Year on for Mpox.

Journal article

Cheyne A. et al, (2024), Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 79, 278 - 280

Nipah virus disease: what can we do to improve patient care?

Journal article

Hassan MZ. et al, (2024), The Lancet Infectious Diseases, 24, e463 - e471

Interpretations of Studies on SARS-CoV-2 Vaccination and Post-acute COVID-19 Sequelae.

Journal article

Gonçalves BP. et al, (2024), Epidemiology (Cambridge, Mass.), 35, 368 - 371

High-dose corticosteroid therapy in COVID-19: the RECOVERY trial - Authors' reply.

Journal article

Peto L. et al, (2024), Lancet (London, England), 403, 1339 - 1340

Mpox: The alarm went off. Have we gone back to sleep?

Journal article

Olliaro P. et al, (2024), PLOS Neglected Tropical Diseases, 18, e0011871 - e0011871

Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19

Journal article

Kartsonaki C. et al, (2023), International Journal of Epidemiology, 52, 355 - 376

Randomised controlled trials for mpox in endemic countries.

Journal article

Rojek A. et al, (2023), The Lancet. Infectious diseases, 23

Facilitating participation in clinical trials during pregnancy.

Journal article

Vousden N. et al, (2023), BMJ (Clinical research ed.), 380

MOSAIC: A cohort study of human mpox virus disease.

Journal article

Pesonel E. et al, (2023), Wellcome open research, 8

Load More